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Introduction: Skin flap necrosis is a challenging problem in 
reconstructive surgery. Pharmacologic administration that 
increases skin flap survaival has been investigated extensively. 
It has been reported that substance P, a member of tachykinin 
family neuropetides, stimulates vessel growth in a variety of 
angiogenesis assays. The purpose of this study was to evaluate 
the effects of local administration of substance P on skin flap 
survival in rat model. 
Materials and Methods: Twenty-four male Sprague-Dawley 
rats were randomly divided into two groups of twelve. Rats 
were anesthetized, and a skin flap, measuring 10 × 3 cm was 
designed on the rat dorsum. After local injections of 1ml 
substance P (100nmol) or normal saline (control) at the distal 
half, the skin flaps were elevated. Then the flaps were 
immediately sutured back in situ. 7 days after the flap elevation, 
survival rate of the flap was calculated and a histological 
examination was performed. 
Results: The mean survival rate of flaps in substance P 
administration group (80.4±7.0%) was significantly higher than 
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that in control group (61.9±6.9%)(p<0.001). Histological 
observation of the flaps showed increase of vessel number in 
the group treated with substance P when compared with the 
control group.  
Conclusion: The results demonstrate that the use of local 
administration of substance P increases skin flap survival in 
rats by enhanced vessel number. 
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Skin flaps have been used extensively as a reconstructive 
option in the field of plastic surgery. However, in all skin flaps, 
distal flap necrosis resulting in failed reconstruction remains a 
serious complication. This applies particularly for the distal part 
of the flap that covers the initial defect. Many factors are 
related to the flap necrosis, involving some local and systemic 
causes, but in most cases, the main reason is arterial 
insufficiency, venous congestion or both. 
Many approaches have been attempted to reduce distal part 
flap necrosis. Among them, flap delay is probably the most 
effective method but requires at least one additional surgical 
intervention with its inherent drawbacks. Another approach is 
the perioperative use of pharmacologic agents to enhance flap 
perfusion and survival. Studies have investigated the effect of 
systemic, local, and combined pharmaceutical applications on 
flap survival. It has been shown that an important factor of flap 
survival is the effect of angiogenesis.  
Substance P is a member of tachykinin family neuropeptides 
which are small molecules secreted from the peripheral 
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terminals of sensory nerve fibers and act as neurotransmitter 
or hormone1. It mediates pain perception2, regulates wound 
healing3 and has a potential to induce angiogenesis4-8.  
It has been demonstrated that substance P, via direct or 
indirect effects on endothelial cells, induces vasodilation and 
plasma extravasation in vivo9. Migration and proliferation of 
endothelial cells10, as well as proliferation of smooth muscle 
cells is induced by substance P in vitro11 12. And also substance 
P-enhanced endothelial cell proliferation and in vivo 
angiogenesis are mimicked by selective NK1 receptor agonist 
and inhibited by antagonists of neurokinin receptors13. 
Although it has been demonstrated that substance P has 
multifunctional nature of both angiogenic and chemotactic 
activities, there is no experimental report about the effect of 
local administration of substance P on skin flap survival. 
In this regard, the author hypothesis that local administration 
of substance P might be beneficial in reducing necrosis in 
ischemic skin flaps and enhancing the survival rate of skin flap 




MATERIALS AND METHODS 
 
Animals and Treatment 
Twenty four male Sprague-Dawley rats weighting around 
300g were used in this experimental study. The rats received 
humane care in accordance with the Guide for the Care and Use 
of Laboratory Animals (National Research Council) and were 
managed in a regulated airflow room, where temperature, 
humidity, and light were controlled. The rats were randomly 
divided into two groups of twelve each. All rats were 
anesthetized with intramuscular injection of ketamine (75mg/kg) 
and xylazine (3mg/kg), and then the dorsal trunk was shaved 
with electric clippers. From the dorsum of the prepared rats, a 
cranially based 10 × 3cm flap was designed with its base on the 
lower margin of the scapula. In the treatment group, 1ml of 
substance P (Sigma-Aldrich Co., St. Louis, MO) solution   
(100nmol) was subcutaneously injected into ten marked sites 
(0.1ml/site) at the distal half of the flap (Figure 1). In the 
control group, 1ml of normal saline was injected by the same 
method. After injection of the substance P or normal saline, the 
flap including panniculus carnosus muscle was elevated. To 
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prevent the angiogenesis from the bed, a silicone sheet 
(Bioplexus corporation® , Ventura, CA) was placed on the flap 
bed. After hemostasis, the flap was sutured back with a 4-0 
nylon suture to its original location. To avoid the possibility that 
the rats would bite the flaps after they recovered from 
anesthesia, each rat was placed in separate cage.  
 
Evaluation of skin flap survival rate 
The flap survival rate was evaluated on postoperative day 7. 
The rats were sacrificed and a writable transparent paper was 
placed over the dorsum of each rat, accounting for the 
curvature of the dorsal surface, and the flap was traced taking 
care to draw the line of demarcation between the viable 
proximal flap tissue and the necrotic distal portion. Flap tracing 
analysis was performed digitally after each flap tracing was 
scanned into a computer as an image file. The images were then 
analyzed using ImageJ software (Wayne Rasband, NIH) to 
determine the percentage of survival rate of each flap. A 
straight line was digitally drawn connecting the tracings 
representing the cranial ends of the lateral incisions. Results 
were expressed as percentages of surviving area in relation to 
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the total flap surface area. 
 
Histological evaluation 
7 days after the flap elevation, skin specimens were taken 
from the surviving district near the demarcation of survival and 
necrotic areas, 1×1cm in size. And then specimens were fixed 
in 10% formaldehyde solution for 24h, embedded in paraffin for 
hematoxylin and eosin (H&E) staining to detect capillaries in 
each group. Angiogenesis was assessed by averaging the 
number of mature vessels containing erythrocytes in 
subcutaneous tissue in 5 randomly chosen fields of 
microphotograph (200 × magnification). 
 
Statistical evaluation 
Statistical analysis was performed using SPSS version 19 
statistical software. Each measurement is shown as 
mean±standard deviation. All pairwise differences between the 
measurements of two groups were examined by a Mann-






Survival rate of skin flap in rats 
According to the examination of the flap survival on 
postoperative day 7, all flaps showed clear demarcation 
between necrotic and survival areas (Figure 2). And distal 
areas of skin flap that were hard or covered with crust were 
judged to be necrotic. The mean percentage of the survival area 
in the substance P treatment group was 80.4±7.0%, and the 
mean of the control group was 61.9±6.9% (Figure 3). The 
results between the group injected with substance P and the 
control group were statistically significant (p < 0.001) based on 
analysis of variance with the Mann-Whitney test. 
 
Histological observation 
According to the examination of the surviving skin tissue near 
the demarcation between necrotic and survival areas,  
improvement of angiogenesis in flaps was observed in 
substance P treatment group demonstrated by significantly 
higher vessel number (4.6 ± 1.8) compared with the control 
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Figure 1. Design of the skin flap. A cranially based 10 × 3cm 
flap was designed with its base on the lower margin of the 










Figure 2. Comparison of survival and necrotic skin flap regions  
on postoperative day 7 in the substance P treatment group (Left) 
and control group (Right). The flaps showed clear demarcation 










Figure 3. Comparison of mean survival rate of flaps between the 
two groups on postoperative day 7. The mean percentage of the 
survival area in the substance P treatment group was 
80.4±7.0%, and the mean of the control group was 61.9±6.9%. 
Substance P increased survival rate of skin flap in rats (***p< 


















Figure 4. Histological view of the subcutaneous layer of the 
cross sections (magnification, ×200). Higher vessel number in 
treatment group (a, b) compared with the control group(c, d). 
The average number of mature vessels containing 
erythrocytes(arrows) per site in subcutaneous layer of each flap 
tissues from the surviving district near the demarcation between 












                                                       
Figure 5. Comparison of vessel number between the two groups. 
Substance P treatment group demonstrated by significantly 
higher mean vessel number (4.6 ± 1.8) compared with the 

















Defect coverage using skin flaps is very common in plastic 
and reconstructive surgery. Adequate vascularity is the most 
important factor for survival of the flaps, and partial or 
complete flap necrosis can result from injuries to the 
vascularity or the inaccurate design of the flap.  
Many techniques have been introduced to minimize these 
problems. The surgical delay method has been used previously 
for increased viability of the flap, but this method has the 
disadvantage of requiring two operations. Subsequently, many 
pharmacological agents have been introduced to limit or reduce 
ischemia of the skin flap. These agents include sympatholytics, 
vasodilators, calcium channel blockers, hemorheological agents, 
prostaglandin inhibitors, anticoagulants, glucocorticoids, and 
free radical scavengers. However, most of the agents are for 
systemic applications and have to be introduced in high doses, 
and thus some incidence of systemic side effects is a risk. To 
overcome these disadvantages, topically applied drugs such as 
nonivamide, nicoboxil and tadalafil have been introduced, but 
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their effects are limited. 
Although a large number of vasoactive-vasodilating agents 
are reported to possess angiogenic activity14-17, the relevance 
of vasodilation to the angiogenesis process is largely unknown. 
Endothelium-dependent vasodilation has been clearly 
demonstrated to be caused by the endothelium-derived 
relaxing factor identified as nitric oxide (NO)18 19, which acts at 
the cellular level by increasing cyclic guanosine monophosphate 
(GMP)20. 
The tachykinin substance P is released when noxious stimuli 
activate the peripheral endings of primary sensory neurons, 
causing vasodilation and increased vascular permeability. The 
vasorelaxant response to substance P is endothelium dependent 
and is mediated by NK1 receptors21 22. Previous investigations 
have shown that substance P activates cyclic GMP production in 
the capillary endothelium23 and that NO-generating drugs 
promote endothelial cell proliferation in vitro24. 
The present study evaluated effects of local administration of 
substance P on viability in rat dorsal skin flap. When the 
survival area was calculated 7 days after elevation, the flap 
survival rate was significantly higher in substance P-injected 
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group (80.4±7.0%) than in the control group (61.9±6.9%) 
(p<0.001). Furthermore, histological observation showed that 
vessel number of the flap is increased in substance P-injected 
group. This result indicate that angiogenesis did occur when 
substance P had been injected. 
However, angiogenesis itself cannot explain the benefit of 
substance P application to the flap. Nitric oxide (NO) seems to 
play a significant role. NO is the one of the key regulators in 
tissue perfusion. It is mainly produced in endothelial cells by 
the endothelial isoform of nitric oxide synthase (eNOS), which 
has been reported causing endothelium to vasodilate25. 
Previous reports from Ziche et al and others have indicated 
that substance P, via NK1 receptors, promotes angiogenesis in 
vivo, endothelial cell growth, and mobilization in vitro. And NO 
production induced by vasoactive agents, such as substance P, 
functions as an autocrine regulator of the microvascular events 
necessary for neovascularizaiton and mediates angiogenesis. 
The results of this experimental study showed that substance 
P, as an effective vasoactive agent, enhances the vessel number 
of the flap and increases survival rate of skin flaps in rats. 
However it requires sufficient time and a suitable dose to act as 
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an angiogenetic factor for increasing flap vascularity and 



















The angiogenic properties of tachykinin neuropeptide 
substance P, after local administration at the distal half of 
cranially orientated skin flap in rats, had a clear beneficial 
effect on the survival of the flap, in a dose of 100nmol. 
Enhancement of vessel number was obvious at the flap treated 
with substance P. On the basis of present findings in this study, 
The author think that substance P may thus represent a 
therapeutic potential in improving skin flap survival in clinical 
settings. However, further investigation is needed to better 
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서론: 피부 피판에서 발생하는 괴사(necrosis)는 재건성형 분야에서 
해결해야 하는 과제 중 하나로 주목 받고 있으며 약물의 투여를 
통해 피부 피판의 괴사를 줄이고 생존율을 향상시키는 연구들이 
광범위하게 진행되고 있는 실정이다. P물질은 말초신경의 말단에서 
분비되는 신경전달 물질 중 하나인데 여러 가지 기전을 통해 
혈관의 신생(angiogenesis)과 성장을 촉진하는 기능을 발휘하고 
있다고 보고 된바 있다. 본 실험의 목적은 P물질의 이러한 기능을 
전제로 국소적인 투여를 통해 쥐 피부 피판의 생존율을 높일 수 
있는 지에 대해 고찰하고 자 한다. 
방법: 총 24마리의 흰 쥐가 실험에 사용되었고 군 당 12마리씩, 
P물질을 투여하는 실험군과 생리식염수를 투여하는 대조군으로 
나누어 실험을 진행하였다. 마취된 쥐의 등에 10 × 3 cm 크기의 
피부 피판을 디자인 후, 피판의 먼 쪽(distal) 2분의 1되는 부분에 
각각 1ml의 P물질(100nmol)과 같은 양의 생리식염수를 균일하게 
피하조직층(subcutaneous layer)으로 주입한다. 다음 디자인 된 
피판을 거상(elevation)하고 즉시 원 위치에 다시 봉합시킨다. 봉합 
후 7일 째 되는 날, 피부 피판의 생존율을 측정하였고 피판에 대한 
조직학적 검사를 시행하였다. 
결과: P물질을 투여한 실험군에서 피부 피판의 생존율이 
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80.4±7.0%로 대조군의 61.9±6.9%에 비해 통계학적으로 
유의하게 높아졌음이 관찰되었다(p<0.001). 조직학적 소견으로는 
대조군에 비해 실험군에서 피판의 혈관 개수(vessel number)가 
유의하게 증가하였음을 알 수 있었다. 
결론: 본 실험의 결과로부터 알 수 있는 바, 쥐에서 P물질을 
국소적으로 피부 피판에 투여하면 혈관 개수(vessel number)가 
증가하여 피판의 생존율을 제고시킬 수 있다. 
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